Jacob Vogelstein

Jacob Vogelstein

Signal active

Co-Founder and Managing Partner

Bio

Jacob Vogelstein is a Co-Founder and Managing Partner at Catalio Capital Management, LP. He attended The Johns Hopkins University School of Medicine.

Location

Bethesda, Maryland, United States, North America

Social

Primary Organization

Catalio Capital Management

Catalio Capital Management

Founded

2016

Investment

71

Lead investment

22

Exits

15

Employees

11-50

Industry

Financial Services, Venture Capital, Biotechnology, Business Development

Jobs history

6

NextPoint Therapeutics

Board Member

Invalid date - Current

Haystack Oncology

Board Member

2022 - Current

Proto Axiom

Non-executive director

Invalid date - Current

Pheast Therapeutics

Board Member

Invalid date - Current

Catalio Capital Management

Co-Founder and Managing Partner

2020 - Current

Iambic Therapeutics

Board Member

Invalid date - Current

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Jacob Vogelstein is the Co-Founder and Managing Partner at Catalio Capital Management, based in United States, North America. With a background in Financial Services, Jacob Vogelstein has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

N/A

Investment portfolio

N/A

Number of investment

1

Number of exits

0

Personal investment

0

There is no personal investment available on this profile

Partner investment

8

Annouced DateOrganization NameFunding RoundInvestor NameMoney Raised
Nov 16, 2022
Haystack Oncology Haystack Oncology
Series A - Haystack Oncology
Haystack Oncology Catalio Capital Management
56.0M
Oct 03, 2023
Iambic Therapeutics Iambic Therapeutics
Series B - Iambic Therapeutics
Iambic Therapeutics Catalio Capital Management
100.0M
Feb 14, 2024
NextPoint Therapeutics NextPoint Therapeutics
Series B - NextPoint Therapeutics
NextPoint Therapeutics Catalio Capital Management
42.5M
Mar 20, 2024
Clasp Therapeutics Clasp Therapeutics
Series A - Clasp Therapeutics
Clasp Therapeutics Catalio Capital Management
150.0M

Exits

0

There is no exit available on this Profile

Invest in industries

Recent Activity

There is no recent news or activity for this profile.